Cigarette Smoking Behavior
16
2
3
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
5 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
Generalized and Domain-Specific Episodic Thinking for Smoking Cessation
Effects of Tobacco Abuse Liability-dependent Taxes in the ETM
An Experimental Evaluation of Menthol-Flavored Tobacco Accessories
Effects of Cigarette and E-cigarette Flavors on Substitutability in the ETM
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Enhancing Source Credibility in Tobacco Regulatory Communications
Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Impact of Cigarette Pack Constituent Disclosures
OCAST Cessation Study
Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking